Literature DB >> 219975

Activation of the alternative pathway of complement by Entamoeba histolytica.

L Ortiz-Ortiz, R Capin, N R Capin, B Sepúlveda, G Zamacona.   

Abstract

A cytopathogenic effect was observed when Entamoeba histolytica was exposed to human sera from individuals with no clinical history or laboratory evidence of amoebiasis. Absorption studies showed that the effect was not due to natural antibodies. Studies performed using ethylenediamine tetracetic acid (EDTA), cobra venom factor (CoF) and heat-inactivation at 56 degrees C, indicated that the cytopathogenic effect was complement dependent. Furthermore, by using ethylene glycol tetracetic acid (EGTA) and Mg++, zymosan, heat-inactivation at 50 degrees C to destroy the activity of factor B of the alternative pathway, as well as electrophoretic studies with anti-human factor B, it was possible to determine that E. histolytica activated the properdin pathway. Finally, complement determinations indicated that incubation of E. histolytica with normal human serum consumed complement. The diminution in CH50 correlated with a consumption of C3 but not of C1, C4 and C2. It was concluded from these results that trophozoites of E. histolytica activate the alternative pathway of the human complement system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 219975      PMCID: PMC1537474     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.

Authors:  L BLUM; L PILLEMER; I H LEPOW
Journal:  Z Immun exp ther       Date:  1959 Oct-Nov

2.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  Experimental amebiasis. II. Hepatic amebiasis in the newborn hamster.

Authors:  C F Mattern; D B Keister
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

5.  Activation of the alternative pathway of the complement system by radiographic contrast media.

Authors:  C M Arroyave; K N Bhat; R Crown
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

Review 6.  The epidemiology of amoebiasis.

Authors:  R Elsdon-Dew
Journal:  Adv Parasitol       Date:  1968       Impact factor: 3.870

7.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  [Determination of the alternative complement pathway in patients with amebic liver abscess].

Authors:  M R Capin; M Jiménez; G Zamacona; L Ortíz-Ortíz
Journal:  Arch Invest Med (Mex)       Date:  1978

9.  [Determination of the immunological effects of immune serum and gammaglobulin on trophozoites of E. histolytica].

Authors:  B Sepúlveda; L Ortiz-Ortiz; A Chévez; M Segura
Journal:  Arch Invest Med (Mex)       Date:  1974

10.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

View more
  14 in total

1.  Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.

Authors:  M F Shaio; J G Chen
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.

Authors:  J Calderon; R Tovar
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

Review 3.  Immune phenomena in amebiasis.

Authors:  R R Kretschmer
Journal:  Surv Immunol Res       Date:  1984

4.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage.

Authors:  R A Salata; R D Pearson; J I Ravdin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

7.  The role of mannose in the receptor of the monocyte locomotion inhibitory factor produced by Entamoeba histolytica.

Authors:  R R Kretschmer; E M Castro; G Pacheco; G Rico; O Díaz-Guerra; J Arellano
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

8.  Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).

Authors:  C Hamelmann; B Urban; B Foerster; R D Horstmann
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Activation of the alternative complement pathway by Trichomonas vaginalis.

Authors:  F D Gillin; A Sher
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Trophozoites of Entamoeba histolytica express a CD59-like molecule in human colon.

Authors:  J Ventura-Juárez; R Campos-Rodríguez; R A Jarillo-Luna; L Muñoz-Fernández; J A Escario-G-Trevijano; J Pérez-Serrano; J L Quintanar; E Salinas; F R Villalobos-Gómez
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.